Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Dow
Baxter
Harvard Business School
Mallinckrodt
Medtronic
Merck

Last Updated: October 21, 2019

DrugPatentWatch Database Preview

SOTRADECOL Drug Profile

See Plans and Pricing

« Back to Dashboard

When do Sotradecol patents expire, and when can generic versions of Sotradecol launch?

Sotradecol is a drug marketed by Elkins Sinn and Mylan Institutional and is included in two NDAs.

The generic ingredient in SOTRADECOL is sodium tetradecyl sulfate. There are one thousand four hundred and seventy-two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the sodium tetradecyl sulfate profile page.

Summary for SOTRADECOL
Drug patent expirations by year for SOTRADECOL
Recent Clinical Trials for SOTRADECOL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
American Rhinologic SocietyN/A
University of Minnesota - Clinical and Translational Science InstituteN/A
BTG International Inc.Phase 2

See all SOTRADECOL clinical trials

US Patents and Regulatory Information for SOTRADECOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Elkins Sinn SOTRADECOL sodium tetradecyl sulfate INJECTABLE;INJECTION 005970-004 Approved Prior to Jan 1, 1982 DISCN Yes No   Start Trial   Start Trial   Start Trial
Mylan Institutional SOTRADECOL sodium tetradecyl sulfate INJECTABLE;INJECTION 040541-002 Nov 12, 2004 RX No Yes   Start Trial   Start Trial   Start Trial
Elkins Sinn SOTRADECOL sodium tetradecyl sulfate INJECTABLE;INJECTION 005970-005 Approved Prior to Jan 1, 1982 DISCN Yes No   Start Trial   Start Trial   Start Trial
Mylan Institutional SOTRADECOL sodium tetradecyl sulfate INJECTABLE;INJECTION 040541-001 Nov 12, 2004 RX No Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Johnson and Johnson
Mallinckrodt
Express Scripts
Merck
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.